BMA 031 effectively reverses steroid-resistant rejection in renal transplants.
Pfeffer
P F
PF
Surgical Department B, Rikshospitalet, Oslo, Norway.
Jakobsen
A
A
Albrechtsen
D
D
Sødal
G
G
Brekke
I
I
Bentdal
O
O
Leivestad
T
T
Fauchald
P
P
Flatmark
A
A
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D007958:Leukocyte Count; D009894:Opportunistic Infections / Q000150:complications; D013256:Steroids / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D013256:Steroids